Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients

British Journal of Cancer ◽

10.1038/bjc.1985.144 ◽

1985 ◽

Vol 52 (1) ◽

pp. 31-35 ◽

Author(s):

M Dowsett ◽

S J Santner ◽

R J Santen ◽

S L Jeffcoate ◽

I E Smith

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Low Dose ◽

Postmenopausal Breast Cancer ◽

Breast Cancer Patients ◽

Effective Inhibition

Download Full-text

Modulation of natural killer cell activity in stage I postmenopausal breast cancer patients on low-dose aminoglutethimide

Cancer Immunology Immunotherapy ◽

10.1007/bf00199836 ◽

1987 ◽

Vol 24 (1) ◽

Author(s):

John Berry ◽

BridgetJ. Green ◽

DavidS. Matheson

Keyword(s):

Breast Cancer ◽

Natural Killer Cell ◽

Cancer Patients ◽

Low Dose ◽

Natural Killer Cell Activity ◽

Killer Cell ◽

Cell Activity ◽

Postmenopausal Breast Cancer ◽

Breast Cancer Patients ◽

Killer Cell Activity

Download Full-text

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients

British Journal of Cancer ◽

10.1038/bjc.1985.223 ◽

1985 ◽

Vol 52 (4) ◽

pp. 525-529 ◽

Author(s):

M Dowsett ◽

A L Harris ◽

R Stuart-Harris ◽

M Hill ◽

B M Cantwell ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Low Dose ◽

Postmenopausal Breast Cancer ◽

Breast Cancer Patients ◽

Endocrine Effects

Download Full-text

Endometrial ablation for prevention of recurrent endometrial pathology in postmenopausal breast cancer patients receiving tamoxifen

10.26442/2079-5831_17.1.41-44 ◽

2015 ◽

Vol 17 (1) ◽

pp. 41-44

Author(s):

I.O. Mamikonyan ◽

◽

S.E. Sarkisov ◽

M.A. Boiko ◽

S.A. Gyurdjyan ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Postmenopausal Breast Cancer ◽

Endometrial Ablation ◽

Breast Cancer Patients ◽

Endometrial Pathology

Download Full-text

265 Endocrine effects of low dose aminoglutethimide without hydrocortisone in breast cancer patients

Journal of Steroid Biochemistry ◽

10.1016/0022-4731(83)91765-x ◽

1983 ◽

Vol 19 ◽

pp. 88

Author(s):

R. Stuart-Harris ◽

M. Dowsett ◽

A. D'Souza ◽

S.L. Jeffcoate ◽

I.E. Smith

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Low Dose ◽

Breast Cancer Patients ◽

Endocrine Effects

Download Full-text

Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy

Breast Cancer Research ◽

10.1186/bcr2320 ◽

2009 ◽

Vol 11 (3) ◽

Author(s):

Christos Markopoulos ◽

Urania Dafni ◽

John Misitzis ◽

Vasilios Zobolas ◽

Evagelos Tzoracoleftherakis ◽

...

Keyword(s):

Breast Cancer ◽

Lipid Profile ◽

Cancer Patients ◽

Hormonal Therapy ◽

Detrimental Effect ◽

Postmenopausal Breast Cancer ◽

Adjuvant Hormonal Therapy ◽

Breast Cancer Patients

Download Full-text

Endometrial findings in postmenopausal breast cancer patients receiving tamoxifen

European Journal of Obstetrics & Gynecology and Reproductive Biology ◽

10.1016/0028-2243(93)90128-y ◽

1993 ◽

Vol 49 (1-2) ◽

pp. 86

Author(s):

E. Lahti ◽

G. Blanco ◽

A. Kauppila ◽

T. Laatikainen

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Postmenopausal Breast Cancer ◽

Breast Cancer Patients

Download Full-text

Different Coexisting Gynecological and Endometrial Pathologies in Postmenopausal Breast Cancer Patients Treated with Tamoxifen

Gynecologic and Obstetric Investigation ◽

10.1159/000010015 ◽

1998 ◽

Vol 46 (2) ◽

pp. 123-129 ◽

Author(s):

Ilan Cohen ◽

Yoram Beyth ◽

Joelle Bernheim ◽

Jeremiah Shapira ◽

Mario Cordoba ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Postmenopausal Breast Cancer ◽

Breast Cancer Patients

Download Full-text

In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients

Clinical & Experimental Immunology ◽

10.1111/j.1365-2249.2010.04167.x ◽

2010 ◽

pp. no-no ◽

Author(s):

S. Meraviglia ◽

M. Eberl ◽

D. Vermijlen ◽

M. Todaro ◽

S. Buccheri ◽

...

Keyword(s):

Breast Cancer ◽

T Cells ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Low Dose ◽

Interleukin 2 ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Vγ9vδ2 T Cells

Download Full-text

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole

OncoTargets and Therapy ◽

10.2147/ott.s115058 ◽

2016 ◽

Vol Volume 9 ◽

pp. 6029-6036 ◽

Author(s):

Shengliang Sun ◽

Fuchao Wang ◽

Honglei Dou ◽

Longqiang Zhang ◽

Jiwen Li

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Postmenopausal Breast Cancer ◽

Breast Cancer Patients ◽

Preventive Effect

Download Full-text

Corrigendum to “Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study” [The Breast, 44, April 2019, 52–58]

10.1016/j.breast.2019.03.007 ◽

2019 ◽

Vol 45 ◽

pp. 118

Author(s):

Kari Britt Hagen ◽

Turid Aas ◽

Jan Terje Kvaløy ◽

Håvard Søiland ◽

Ragna Lindb

Keyword(s):

Breast Cancer ◽

Prospective Study ◽

Cancer Patients ◽

Endocrine Therapy ◽

Postmenopausal Breast Cancer ◽

Adjuvant Endocrine Therapy ◽

Breast Cancer Patients

Download Full-text